Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 18Peripheral Blood Stem Cell Transplantation 13Filgrastim 12Etoposide 11Rituximab 10Vincristine 9Radiotherapy 9Doxorubicin 8Cytarabine 8Cyclosporine 8fludarabine phosphate 6Prednisone 6Cisplatin 6tanespimycin 5aldesleukin 5Melphalan 5Ifosfamide 5Busulfan 5Vorinostat 4Paclitaxel 4Methylprednisolone 4Methotrexate 4Gemcitabine 4Antilymphocyte Serum 4sargramostim 3bryostatin 1 3VAP-cyclo protocol 3Prednisolone 3Mycophenolic Acid 3Irinotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lymphoma, Large-Cell, Immunoblastic × lonafarnib × Clear all
NCT00003956 2013-04-04

Combination Chemotherapy in Treating Patients With Advanced Cancer

National Cancer Institute (NCI)

Phase 1 Completed
25 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡